N-乙酰基-1,3-丙二胺 | 4078-13-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N-乙酰基-1,3-丙二胺
• 中文别名: N-(3-氨基丙基)-乙酰胺
• 英文名称: N-(3-aminopropyl)acetamide
• CAS: 4078-13-1
• 化学式: C₅H₁₂N₂O
• mdl: MFCD09863401
• 分子量: 116.163
• InChiKey: YFZBPSXRYCOKCW-UHFFFAOYSA-N

物化性质

• 沸点：
  130 °C(Press: 3 Torr)
• 密度：
  0.9879 g/cm3
• 溶解度：
  可溶于氯仿、乙酸乙酯

计算性质

• 辛醇/水分配系数(LogP)：
  -1
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  55.1
• 氢给体数：
  2
• 氢受体数：
  2

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: N-(3-Aminopropyl)acetamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: N-(3-Aminopropyl)acetamide
CAS number: 4078-13-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H12N2O
Molecular weight: 116.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-乙酰基-1,3-丙二胺 在 palladium/alumina 作用下， 以 xylene 为溶剂， 反应 48.0h， 生成 2-甲基嘧啶
  参考文献：
  名称：

  The spectroscopic and photophysical effects of the position of methyl substitution. II. 2‐methylpyrimidine

  摘要：

  Laser-induced fluorescence excitation and dispersed fluorescence spectra of the first n–π* transition of jet-cooled 2-methylpyrimidine have been recorded and analyzed. This work extends our earlier study of the spectroscopic and photophysical effects of methyl substitution in 4- and 5-methylpyrimidine. An unusual Fermi resonance involving the 6an0 progression forms the focus of the present study. The 6a10 vibronic transition is observed to be split into a triad of transitions. Dispersed fluorescence spectra are used to identify the dark background state responsible for the Fermi resonance coupling as the 16b1(3a′′2) vibration/internal rotation combination level. This level is selectively coupled by symmetry constraints to 6a1(0a1), leaving the 6a1(1e″) level unperturbed. The positions and intensities of the triad of peaks in the excitation spectrum allow a quantitative determination of the 6a1(0a′1)↔16b1(3a2) coupling matrix element of V=4.1 cm−1. This vibration/internal rotation Fermi resonance is thus typical of the new types of routes to vibrational state mixing which are opened by methyl substitution. Higher members of the 6an0 progression are also involved in Fermi resonance mixing. However, in addition, these levels experience weaker, less state-specific coupling to a bath of same-symmetry states at that energy. The excitation spectrum provides an estimate of the average coupling matrix element of this second tier coupling of ∼1 cm−1.

  DOI：

  10.1063/1.462121
• 作为产物：
  描述：

  N-acetyl-2-cyanoethylamine 在 镍 作用下， 60.0 ℃ 、27.46 MPa 条件下， 生成 N-乙酰基-1,3-丙二胺
  参考文献：
  名称：

  合成抗疟药；某些4-氨基喹啉的制备。

  摘要：

  DOI：

  10.1021/ja01211a021

文献信息

• [EN] THIAZOLECARBOXAMIDE DERIVATIVES FOR USE AS NAMPT INHIBITORS<br/>[FR] DÉRIVÉS DE THIAZOLECARBOXAMIDE UTILES EN TANT QU'INHIBITEURS DE LA NAMPT
  申请人：ABBVIE INC

  公开号：WO2013170118A1

  公开（公告）日：2013-11-14

  Disclosed are compounds which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is expressed.

  揭示了抑制NAMPT活性的化合物，包含这些化合物的组合物以及治疗NAMPT表达期间的疾病的方法。
• Disrupting the Conserved Salt Bridge in the Trimerization of Influenza A Nucleoprotein
  作者：Jennifer L. Woodring、Shao-Hung Lu、Larissa Krasnova、Shih-Chi Wang、Jhih-Bin Chen、Chiu-Chun Chou、Yi-Chou Huang、Ting-Jen Rachel Cheng、Ying-Ta Wu、Yu-Hou Chen、Jim-Min Fang、Ming-Daw Tsai、Chi-Huey Wong

  DOI：10.1021/acs.jmedchem.9b01244

  日期：2020.1.9

  threat to public health. To develop a broad-spectrum inhibitor of influenza to combat the problem of drug resistance, we previously identified the highly conserved E339...R416 salt bridge of the nucleoprotein trimer as a target and compound 1 as an inhibitor disrupting the salt bridge with an EC50 = 2.7 μM against influenza A (A/WSN/1933). We have further modified this compound via a structure-based

  流感感染中的抗病毒药物耐药性已成为对公共卫生的主要威胁。为了开发广谱的流感抑制剂来解决耐药性问题，我们之前确定了高度保守的核蛋白三聚体E339 ... R416盐桥为靶标，化合物1为通过EC50破坏盐桥的抑制剂甲型流感病毒= 2.7μM（A / WSN / 1933）。我们通过基于结构的方法进一步修饰了该化合物，并进行了抗病毒活性筛选，以鉴定化合物29和30的EC50值分别为110和120 nM，并且没有可测量的宿主细胞毒性。与临床使用的神经氨酸酶抑制剂相比，这两种化合物对耐药性A型流感病毒株和B型流感病毒显示出更好的活性，
• Cephem and cepham compounds
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US04390534A1

  公开（公告）日：1983-06-28

  This invention relates to novel 7-thiadiazol-oxyimino-3-cephem and cepham 4-carboxylic acid compounds of high antimicrobial activity.

  这项发明涉及具有高抗微生物活性的新型7-噻二唑氧肟基-3-头孢菌素和头孢菌素-4-羧酸化合物。
• Synthesis of New Bis-imidazole Derivatives
  作者：Marcin Jasiński、Grzegorz Mlostoń、Paulina Mucha、Anthony Linden、Heinz Heimgartner

  DOI：10.1002/hlca.200790186

  日期：2007.9

  The reaction of aldimines with α-(hydroxyimino) ketones of type 10 (1,2-diketone monooximes) was used to prepare 2-unsubstituted imidazole 3-oxides 11 bearing an alkanol chain at N(1) (Scheme 2, Table 1). These products were transformed into the corresponding 2H-imidazol-2-ones 13 and 2H-imidazole-2-thiones 14 by treatment with Ac2O and 2,2,4,4-tetramethylcyclobutane-1,3-dithione, respectively (Scheme 3)

  醛亚胺与10型α-（羟基亚氨基）酮（1,2-二酮单肟）的反应用于制备在N（1）带有链烷醇链的2-未取代的咪唑3-氧化物11（方案2，表1） 。通过分别用Ac 2 O和2,2,4,4-四甲基环丁烷-1,3-二硫酮处理，将这些产物转化为相应的2 H-咪唑-2-酮13和2 H-咪唑-2-硫酮14。（方案3）。甲醛10与甲醛1和烷烃1- ω-二胺15的三组分反应生成双[1H-咪唑3-氧化物] 16（方案4，表2）。与Ac 2 O，2,2,4,4-四甲基环丁烷-1,3-二硫酮或Raney -Ni发生反应，得到相应的双[2 H-咪唑-2-酮] 19和20，bis [2 H-咪唑-2-硫酮] 21和双[咪唑] 22（方案5和6）。通过X射线晶体学确定11a和16b的结构。
• Synthesis and Some First-Row Transition-Metal Complexes of the 1,2,4-Triazole-Based Bis(terdentate) Ligands TsPMAT and PMAT
  作者：Marco H. Klingele、Boujemaa Moubaraki、Keith S. Murray、Sally Brooker

  DOI：10.1002/chem.200500387

  日期：2005.11.18

  octahedral, as evidenced by the X-ray crystal structure analyses of [Co(II) (2)(TsPMAT)(2)](BF(4))(4)6 MeCN (246 MeCN) and [Fe(II) 2(PMAT)2](BF4)4DMF (27DMF). Studies of the magnetic properties of [Co(II) 2(TsPMAT)2](BF4)4.4 H2O (244 H2O), [Mn(II) 2(PMAT)2](ClO4)4 (26), and [Co(II) 2(PMAT)2](BF4)4 (28) have revealed weak antiferromagnetic coupling (J=-3.3, -0.16, and -2.4 cm(-1), respectively) between the two

  已经研究了采用基于亲核取代而不是席夫碱缩合的策略来制备1,2,4-三唑基配体，并导致了两种新配体的合成，即4-氨基-3， 5-双[N-（2-吡啶基甲基）-N-（4-甲苯磺酰基）氨基]甲基} -4H-1,2,4-三唑（TsPMAT，14）和4-氨基-3,5-bis [（2-吡啶基甲基）氨基]甲基} -4H-1,2,4-三唑（PMAT，15）。这些是掺入1,2,4-三唑单元的双（齿）配体的第一个实例。TsPMAT（14）与Co（BF4）2.6 H2O形成双核2：2络合物，即使当金属与配体的摩尔比为2：1时也是如此。同样，PMAT（15）与Mn（ClO4）2.6H2O或M（BF4）2.6 H2O（M = Fe，Co，Ni，Zn）配体与金属的摩尔比为1：1的反应提供了通式[M（II）（2）（PMAT）2] X4的一系列配合物。TsPMAT（14）和PMAT（15）的这些络合物中的金属中心被两个配体分子包裹，并被1